Design, Setting, and Participants KET01-03 was an active-comparator, double-blind, double-dummy, crossover phase 1 randomized clinical trial (RCT) conducted among healthy adult male volunteers (aged 18 years) between July and August 2023 at a single trial site in Germany
Mild to moderate bruising is usually not something to worry about
J Am Chem Soc 141:2040720415 Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, Bayir H, Abhari BA, Angeli JPF, Choi SM et al (2018) Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
Emerging technologies are entering the market
Targeted Vitamin Injections: Our programs often include powerful tools that go far beyond what a daily multivitamin can offer